AIMEE CARDENAS: Open Payments
NPI 1669712253 · MONTEREY PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 28 payments from 8 companies in 2025. Trend: 2023 $514 · 2024 $650 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $288 |
| Amgen Inc. | 3 | $70 |
| Corcept Therapeutics | 2 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Lilly USA, LLC | 2 | $47 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ozempic, OTEZLA, Korlym, XIFAXAN, Wegovy, MOUNJARO, ZENPEP, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
